Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions

NCT04379570 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.

NCT NCT04379570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04379570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
Lead sponsor
Alliance for Clinical Trials in Oncology
Phase
Phase 3
Overall status
Active, not recruiting
Start date
February 15, 2021
Completion date
October 31, 2026
Enrollment
1,167 (actual)
Sites
526

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage i breast cancer ajcc v8, anatomic stage ii breast cancer ajcc v8, anatomic stage iii breast cancer ajcc v8, her2 negative breast carcinoma, hormone receptor positive breast carcinoma, invasive breast carcinoma, prognostic stage i breast cancer ajcc v8, prognostic stage ii breast cancer ajcc v8, prognostic stage iii breast cancer ajcc v8